Continuous Microchannel Pharma Synthesis Model
Underwrite 3D-printed silicon carbide microchannel reactors carrying out hazardous exothermic chemical reactions continuously with millisecond heat dissipation (increasing yield from 65% to 98% with 90% reduced plant footprint). Model pharma CDMO manufacturing fees ($3,200/kg API), and 15-yr IRR.
1. Capacity & Unit Economics
2. Financial Returns & Yield
98% CHEMICAL YIELD MICROFLUIDICSAnnual Net EBITDA
$0 / yr
15-Yr Project IRR
0.0%
Gross Revenue
$0 / yr
Total CapEx
$0
Annual OpEx
$0 / yr